A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
暂无分享,去创建一个
J. Rossi | R. Bataille | N. Ifrah | T. Facon | J. Harousseau | M. Attal | Norbert Ifrah | A. Stoppa | Thierry Facon | Jean-Luc Harousseau | J. Sotto | Philippe Casassus | Régis Bataille | Michel Attal | H. Maisonneuve | Anne-Marie Stoppa | Jean-Jacques Sotto | Jean-Gabriel Fuzibet | Jean-François Rossi | Hervé Maisonneuve | C. Payen | P. Casassus | J. Fuzibet | C. Payen
[1] T M Grogan,et al. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] W. Gregory,et al. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Reece,et al. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. , 1993, Bone marrow transplantation.
[4] A. Newland,et al. INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA , 1989, The Lancet.
[5] B. Barlogie,et al. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors , 1990 .
[6] W. Siegert,et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation , 1994, The Lancet.
[7] B. Mazières,et al. Intensive combined therapy for previously untreated aggressive myeloma. , 1992, Blood.
[8] M. Gore,et al. High-dose melphalan for multiple myeloma: long-term follow-up data. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] H. Senn,et al. Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] H. Gadner,et al. A Controlled Trial of Recombinant Human Granulocyte-macrophage Colony-stimulating Factor After Total-body Irradiation, High-dose Chemotherapy, and Autologous Bone-marrow Transplantation for Acute Lymphoblastic-leukemia Or Malignant-lymphoma , 1992 .
[11] T. Hickish,et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.
[13] M. Boccadoro,et al. High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S. Jagannath,et al. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma , 1987 .
[15] B. Barlogie,et al. Plasma cell dyscrasias. , 1992, JAMA.
[16] J. Reiffers,et al. AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN HIGH‐RISK MULTIPLE MYELOMA , 1989, British journal of haematology.
[17] P. Ljungman,et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. , 1995, Bone marrow transplantation.
[18] M. Gore,et al. INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION , 1989, The Lancet.
[19] N. Ifrah,et al. Double-intensive therapy in high-risk multiple myeloma. , 1992, Blood.
[20] M. Dimopoulos,et al. Early myeloablative therapy for multiple myeloma. , 1994, Blood.
[21] H. Wilson,et al. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. , 1969, JAMA.
[22] B. Barlogie,et al. Bone marrow transplantation in multiple myeloma. , 1991, Bone marrow transplantation.
[23] F. Mandelli,et al. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. , 1990, The New England journal of medicine.
[24] H. Lokhorst,et al. High-risk multiple myeloma treated with high-dose melphalan. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] H. Deicher,et al. A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group. , 1995, European journal of cancer.
[26] M. Dimopoulos,et al. Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. , 1993, Blood.
[27] M. Slevin,et al. Multiple myeloma treated with high dose intravenous melphalan , 1987, British journal of haematology.
[28] J. Bourhis,et al. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. , 1995, Bone marrow transplantation.
[29] Zander,et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. , 1986, Blood.
[30] T. Mcelwain,et al. HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA , 1983, The Lancet.
[31] J. Ritz,et al. Monoclonal Antibody-Purged Autologous Bone Marrow Transplantation Therapy for Multiple Myeloma , 1991 .
[32] D. Bergsagel. Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma? , 1989, European journal of cancer & clinical oncology.
[33] P. Ravaud,et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. , 1993, Blood.
[34] H. Prentice,et al. Autologous stem cell transplantation in multiple myeloma: Results of the european group for bone marrow transplantation , 1995, Stem cells.
[35] J. Sporn,et al. Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results. , 1986, Seminars in oncology.
[36] J. Crowley,et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants , 1994 .
[37] J. Bourhis,et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma. , 1995, Stem cells.